These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 1663450

  • 21. [Recent advance of the study of okadaic acid class tumor promoters].
    Yatsunami J, Fujiki H.
    Tanpakushitsu Kakusan Koso; 1993 Jan; 38(1):26-35. PubMed ID: 8383867
    [No Abstract] [Full Text] [Related]

  • 22. Activation of epidermal akt by diverse mouse skin tumor promoters.
    Lu J, Rho O, Wilker E, Beltran L, Digiovanni J.
    Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
    [Abstract] [Full Text] [Related]

  • 23. Cytoskeletal integrity in interphase cells requires protein phosphatase activity.
    Eriksson JE, Brautigan DL, Vallee R, Olmsted J, Fujiki H, Goldman RD.
    Proc Natl Acad Sci U S A; 1992 Nov 15; 89(22):11093-7. PubMed ID: 1332069
    [Abstract] [Full Text] [Related]

  • 24. Tumor necrosis factor-alpha, a new tumor promoter, engendered by biochemical studies of okadaic acid.
    Fujiki H, Suganuma M.
    J Biochem; 1994 Jan 15; 115(1):1-5. PubMed ID: 8188614
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Protein phosphatase inhibitors induce the sustained expression of the Egr-1 gene and the hyperphosphorylation of its gene product.
    Cao X, Mahendran R, Guy GR, Tan YH.
    J Biol Chem; 1992 Jun 25; 267(18):12991-7. PubMed ID: 1320009
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Okadaic acid indicates a major function for protein phosphatases in stimulus-response coupling of RINm5F rat insulinoma cells.
    Mayer P, Jochum C, Schatz H, Pfeiffer A.
    Exp Clin Endocrinol; 1994 Jun 25; 102(4):313-9. PubMed ID: 7813603
    [Abstract] [Full Text] [Related]

  • 30. Unique features of the okadaic acid activity class of tumor promoters.
    Fujiki H, Suganuma M.
    J Cancer Res Clin Oncol; 1999 Jun 25; 125(3-4):150-5. PubMed ID: 10235468
    [Abstract] [Full Text] [Related]

  • 31. Hyperphosphorylation of N-60, a protein structurally and immunologically related to nucleolin after tumour-promoter treatment.
    Issinger OG, Martin T, Richter WW, Olson M, Fujiki H.
    EMBO J; 1988 Jun 25; 7(6):1621-6. PubMed ID: 3139405
    [Abstract] [Full Text] [Related]

  • 32. Okadaic acid and phorbol esters: comparative effects of these tumor promoters on cell transformation, intercellular communication and differentiation in vitro.
    Katoh F, Fitzgerald DJ, Giroldi L, Fujiki H, Sugimura T, Yamasaki H.
    Jpn J Cancer Res; 1990 Jun 25; 81(6-7):590-7. PubMed ID: 2119362
    [Abstract] [Full Text] [Related]

  • 33. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity.
    Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D.
    Biochem Biophys Res Commun; 1989 Mar 31; 159(3):871-7. PubMed ID: 2539153
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of protein phosphatases-1 and -2A with acanthifolicin. Comparison with diarrhetic shellfish toxins and identification of a region on okadaic acid important for phosphatase inhibition.
    Holmes CF, Luu HA, Carrier F, Schmitz FJ.
    FEBS Lett; 1990 Sep 17; 270(1-2):216-8. PubMed ID: 2171991
    [Abstract] [Full Text] [Related]

  • 35. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.
    Fujiki H, Suganuma M.
    Adv Cancer Res; 1993 Sep 17; 61():143-94. PubMed ID: 8394044
    [No Abstract] [Full Text] [Related]

  • 36. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells.
    Chambers TC, Zheng B, Kuo JF.
    Mol Pharmacol; 1992 Jun 17; 41(6):1008-15. PubMed ID: 1377325
    [Abstract] [Full Text] [Related]

  • 37. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on insulin release from rat pancreatic islets.
    Tamagawa T, Iguchi A, Uemura K, Miura H, Nonogaki K, Ishiguro T, Sakamoto N.
    Endocrinol Jpn; 1992 Jun 17; 39(3):325-9. PubMed ID: 1330503
    [Abstract] [Full Text] [Related]

  • 38. T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A.
    Weller M, Malipiero U, Groscurth P, Fontana A.
    Exp Cell Res; 1995 Dec 17; 221(2):395-403. PubMed ID: 7493639
    [Abstract] [Full Text] [Related]

  • 39. Okadaic acid enhances human T cell activation and phosphorylation of an internal substrate induced by phorbol myristate acetate.
    Tada Y, Yoshizawa S, Nagasawa K, Furugo I, Tsuru T, Mayumi T, Tsukamoto H, Niho Y.
    Immunopharmacology; 1992 Dec 17; 24(1):17-24. PubMed ID: 1333455
    [Abstract] [Full Text] [Related]

  • 40. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A.
    Goad DL, Meurer EA, Voelkel EF, Petrou CP, Tashjian AH.
    Endocrinology; 1992 Jun 17; 130(6):3402-10. PubMed ID: 1375901
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.